Market Overview:

The home infusion therapy market is experiencing rapid growth, driven by rising prevalence of chronic diseases and aging population, cost efficiency and hospital avoidance, and government incentives and favorable policy changes. According to IMARC Group’s latest research publication, “Home Infusion Therapy Market Report by Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), Application (Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, and Others), and Region 2025-2033”, the global home infusion therapy market size reached USD 45.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 70.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Download a sample PDF of this report: https://www.imarcgroup.com/home-infusion-therapy-market/requestsample

Our report includes:

• Market Dynamics
• Market Trends and Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Home Infusion Therapy Market

• Rising Prevalence of Chronic Diseases and Aging Population

One of the biggest factors fueling home infusion therapy is the surge in chronic conditions like cancer, diabetes, and heart disease, especially among older adults. Around 805,000 people in the U.S. alone experience heart attacks annually, and 1.9 million new cancer cases are reported yearly. As these long-term illnesses often need extended treatment, care at home helps minimize hospital stays, support patient independence, and enhance comfort. The global aging trend means more patients prefer easy access to therapy at home, reducing the need for frequent trips to healthcare facilities and improving adherence and outcomes.

• Cost Efficiency and Hospital Avoidance

Cost savings are a huge driver behind the shift to home infusion. Home-based treatments slash costs tied to hospital stays, with daily care at home averaging $122 to $225 per day, compared with $586 to $798 for inpatient care. It’s a game-changer for healthcare systems facing rising expenses, freeing up vital hospital beds and resources. Given chronic disease management’s long-term nature, both insurers and patients see significant financial benefits, which makes home infusion therapy far more attractive for treatment continuity and lowers overall healthcare spending.

• Government Incentives and Favorable Policy Changes

Government action is paving the way for wider adoption of home infusion therapy. In the U.S., the 21st Century Cures Act introduced a home infusion benefit under Medicare Part B, expanding insurance coverage for professional services provided at home. New supplier accreditations, easier provider enrollment, and ongoing policy support mean more seamless access to home infusion, especially for seniors and those with mobility issues. Bipartisan bills, such as the Preserving Patient Access to Home Infusion Act, aim to make these benefits permanent and more accessible, illustrating a strong, ongoing commitment to patient-centered care at home.

Key Trends in the Home Infusion Therapy Market

• Digital Health Integration & Smart Infusion Technology

The rise of digital health tools is transforming how patients and providers interact in home infusion therapy. Smart pumps, real-time monitoring, and integrated management platforms are now standard, letting healthcare professionals track progress and make adjustments remotely. For instance, the recent FDA approval of Moog’s CURLIN 8000 ambulatory infusion system introduced tech that enables safer, multi-therapy infusions while keeping patients and pharmacists connected. Such digital integration not only improves safety and efficiency but also boosts patient engagement and reduces the need for in-person visits, paving the way for even more personalized, convenient care.

• Customization and Specialized Infusion Services

A growing focus on personalized healthcare means more tailored infusion therapies, targeting each patient’s unique needs based on their specific chronic condition. Companies like Dynamic Access are now rolling out specialized home infusion nursing, often collaborating with more than 35 specialty pharmacies to provide thousands of home visits for complex illnesses like multiple sclerosis. Customization leads to better treatment adherence and satisfaction. In fact, patient-reported outcomes show those who receive individualized home therapies feel more satisfied and empowered in their treatments compared to traditional hospital stays.

• Expanding Patient Empowerment and Training

Patients are increasingly taking a hands-on role in managing their treatments at home, supported by structured education and training from healthcare teams. Nurses now routinely teach patients and caregivers how to self-administer medications safely, troubleshoot equipment, and handle side effects. This empowerment means a smoother transition from hospital to home, reduced hospital readmissions, and higher satisfaction—especially among elderly patients and those managing rare diseases. Reports show that self-administered therapies at home can prevent thousands of hospital days, giving patients more freedom and flexibility while easing the healthcare system’s burden.

We explore the factors propelling the home infusion therapy market growth, including technological advancements, consumer behaviors, and regulatory changes.

Leading Companies Operating in the Home Infusion Therapy Industry:

• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• Eli Lilly and Company
• Fresenius SE & Co. KGaA
• ICU Medical Inc.
• JMS Co. Ltd.
• Nipro Corporation
• Option Care Health Inc. (Walgreen Co.)
• Smiths Group plc
• Terumo Corporation

Home Infusion Therapy Market Report Segmentation:

By Product:

• Infusion Pumps
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

Infusion Pumps currently hold the largest demand in the home infusion therapy market, dominating due to their precision in medication delivery, exemplified by Baxter's advanced Spectrum IQ pump enhancing patient safety and monitoring.

By Application:

• Anti-Infective
• Endocrinology
  • Diabetes
  • Others
• Hydration Therapy
  • Athletes
  • Others
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Others

Anti-Infectives lead the home infusion therapy market, driven by their critical role in treating severe infections like pneumonia with intravenous antibiotics, supported by systems like Smiths Medical's CADD infusion system for precise delivery.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America dominates the infusion therapy market revenue, accounting for the largest market share, with comprehensive analysis covering major regions including Asia-Pacific, Europe, Latin America, and the Middle East and Africa.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302